These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 22610277)

  • 1. β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer.
    Tenbaum SP; Ordóñez-Morán P; Puig I; Chicote I; Arqués O; Landolfi S; Fernández Y; Herance JR; Gispert JD; Mendizabal L; Aguilar S; Ramón y Cajal S; Schwartz S; Vivancos A; Espín E; Rojas S; Baselga J; Tabernero J; Muñoz A; Palmer HG
    Nat Med; 2012 Jun; 18(6):892-901. PubMed ID: 22610277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
    Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
    Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of FOXO3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer.
    Yang JY; Chang CJ; Xia W; Wang Y; Wong KK; Engelman JA; Du Y; Andreeff M; Hortobagyi GN; Hung MC
    Cancer Res; 2010 Jun; 70(11):4709-18. PubMed ID: 20484037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO3a and β-catenin co-localization: double trouble in colon cancer?
    Yan Y; Lackner MR
    Nat Med; 2012 Jun; 18(6):854-6. PubMed ID: 22673992
    [No Abstract]   [Full Text] [Related]  

  • 5. Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer.
    Chen J; Gomes AR; Monteiro LJ; Wong SY; Wu LH; Ng TT; Karadedou CT; Millour J; Ip YC; Cheung YN; Sunters A; Chan KY; Lam EW; Khoo US
    PLoS One; 2010 Aug; 5(8):e12293. PubMed ID: 20808831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear β-Catenin depend on active PI3K signaling.
    Ormanns S; Neumann J; Horst D; Kirchner T; Jung A
    Oncotarget; 2014 May; 5(10):2999-3011. PubMed ID: 24930890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer.
    Qazi AK; Hussain A; Khan S; Aga MA; Behl A; Ali S; Singh SK; Taneja SC; Shah BA; Saxena AK; Mondhe DM; Hamid A
    Cancer Lett; 2015 Apr; 359(1):47-56. PubMed ID: 25554016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis.
    Lee G; Goretsky T; Managlia E; Dirisina R; Singh AP; Brown JB; May R; Yang GY; Ragheb JW; Evers BM; Weber CR; Turner JR; He XC; Katzman RB; Li L; Barrett TA
    Gastroenterology; 2010 Sep; 139(3):869-81, 881.e1-9. PubMed ID: 20580720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
    Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
    J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear accumulation of β-catenin and forkhead box O3a in colon cancer: Dangerous liaison.
    Link W
    World J Biol Chem; 2012 Sep; 3(9):175-9. PubMed ID: 23024836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells.
    Li Y; Wang Z; Kong D; Murthy S; Dou QP; Sheng S; Reddy GP; Sarkar FH
    J Biol Chem; 2007 Jul; 282(29):21542-50. PubMed ID: 17522055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].
    Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH
    Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis.
    Sarkar M; Khare V; Guturi KK; Das N; Ghosh MK
    Oncogene; 2015 Nov; 34(47):5843-56. PubMed ID: 25745998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
    Fang L; Wang H; Zhou L; Yu D
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia.
    Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C
    J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of PI3K/Akt/FoxO3a and PKA/CREB Signaling Pathways in the Protective Effect of Fluoxetine Against Corticosterone-Induced Cytotoxicity in PC12 Cells.
    Zeng B; Li Y; Niu B; Wang X; Cheng Y; Zhou Z; You T; Liu Y; Wang H; Xu J
    J Mol Neurosci; 2016 Aug; 59(4):567-78. PubMed ID: 27412469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
    Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
    Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Atypical Antipsychotic Agent, Clozapine, Protects Against Corticosterone-Induced Death of PC12 Cells by Regulating the Akt/FoxO3a Signaling Pathway.
    Zeng Z; Wang X; Bhardwaj SK; Zhou X; Little PJ; Quirion R; Srivastava LK; Zheng W
    Mol Neurobiol; 2017 Jul; 54(5):3395-3406. PubMed ID: 27173157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?
    Prossomariti A; Piazzi G; Alquati C; Ricciardiello L
    Cell Mol Gastroenterol Hepatol; 2020; 10(3):491-506. PubMed ID: 32334125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes.
    Chong ZZ; Hou J; Shang YC; Wang S; Maiese K
    Curr Neurovasc Res; 2011 May; 8(2):103-20. PubMed ID: 21443457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.